Key Takeaways:
- ELRIG Research and Innovation 2024 to be held on March 20–21 in Manchester, UK, featuring renowned speakers from the life sciences industry.
- Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics, and animal-free drug discovery, reflecting the latest trends in biomedical research.
- Launch of the TechBio Breakthrough Zone and the Impact Award highlights ELRIG’s commitment to fostering innovation and recognizing early-career professionals in the field.
Cambridge, UK, February 8th, 2024: ELRIG UK, a leading organization dedicated to advancing scientific research and innovation in the life sciences sector, has announced the keynote speakers for its highly anticipated Research and Innovation conference, scheduled to take place at the University of Manchester from March 20th to 21st. Esteemed industry figures Steve Bates OBE FMedSci, CEO of the BioIndustry Association (BIA), and Dr. Anderson Ryan, Co-founder and Head of R&D and Drug Development at FasT BioPharma, will headline this year’s event, focusing on accelerating drug discovery and development to address global healthcare challenges.
Accelerating Drug Discovery: A Focus on Innovation
ELRIG Research and Innovation 2024 will serve as a platform for scientists, researchers, and entrepreneurs to explore cutting-edge advancements in biomedical research and technology. With a diverse range of topics spanning oncology, antimicrobial resistance, mass spectrometry, proteomics, and animal-free drug discovery, the conference aims to facilitate collaboration and knowledge exchange to drive forward the development of novel therapeutics and treatments.
Unveiling the Keynote Speakers: Leaders in Life Sciences
Steve Bates, renowned for his leadership in the UK’s life science industry, will bring his wealth of experience and expertise to the conference. As the CEO of the BIA, Bates has been instrumental in fostering collaboration and innovation within the sector, advocating for next-generation talent development and industrial incentives. His insights into the evolving landscape of life sciences will provide invaluable guidance to attendees seeking to navigate the challenges and opportunities of drug discovery.
Quote from Steve Bates OBE FMedSci, CEO, BioIndustry Association: “I’m delighted to be speaking at ELRIG Research and Innovation this year. The event presents an excellent opportunity for the vibrant life sciences industry to connect, collaborate and discuss the latest innovations. This is vital to the success of the community as we strive towards the discovery and development of new medicines to cure more patients around the world.”
Dr. Anderson Ryan, a pioneer in oncology research and drug development, will also take the stage to share his insights into the latest advancements in the field. With a distinguished career spanning academia and industry, Dr. Ryan brings a unique perspective on translational science and therapeutic innovation. His contributions to the understanding of cancer biology and treatment strategies will provide attendees with valuable insights and inspiration.
Quote from Dr. Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma: “The organisers have put together a terrific line up packed with interesting talks, poster presentations, exhibitors and networking opportunities. I’m proud to be presenting at such an exciting event, providing researchers and entrepreneurs with a host of opportunities to discover emerging biology and cutting-edge technologies, including those from young companies.”
Fostering Innovation and Recognizing Excellence
In addition to the keynote presentations, ELRIG will launch the TechBio Breakthrough Zone, providing emerging companies with a platform to showcase their technologies and innovations. This initiative underscores ELRIG’s commitment to nurturing entrepreneurship and fostering collaboration within the life sciences ecosystem. Furthermore, the Impact Award will recognize early-career professionals who have made significant contributions to the field of drug discovery, highlighting the importance of mentorship and talent development in driving scientific progress.
Quote from Sarah Brockbank, Conference Director, ELRIG UK and Strategy Leader—Complex Medicines, Medicines Discovery Catapult: “We have an outstanding line up of speakers covering key focus areas in drug discovery and development. These world-leading experts will share their insights and experiences on the challenges and opportunities in the field, and we are honoured to have Steve Bates and Dr. Anderson Ryan on board as keynote speakers.”
Quote from Roger Clark, Conference Director, ELRIG UK and Head of High Throughput Screening, Charles River Laboratories: “We look forward to welcoming scientists from academia and industry to the University of Manchester, celebrating its bicentenary this year — the perfect setting to share bold ideas to accelerate future drug discovery and reflect upon the transformative achievements that have paved the way for new generation therapeutics.”
For further information about Research and Innovation 2024, please visit: ELRIG Research and Innovation 2024
About ELRIG UK: ELRIG UK is a not-for-profit volunteer-led organization dedicated to advancing scientific meetings and conferences in the life sciences sector. With a focus on open-access events and collaboration, ELRIG aims to inspire and align with the ESG strategies of its global community. For more information, visit the ELRIG website or follow on LinkedIn, Twitter, and Instagram.
Sign up to our newsletter & get the most important monthly insights from around the world.
Ready to Amplify Your Brand with Business Today?
Discover the power of sponsored articles and partnerships to reach decision-makers, professionals, and a dynamic audience. Learn more about our advertising opportunities and connect with us today!
Click here to explore our Promotion & Sponsored Articles page.
Are you looking to make an impact? Contact us at pitch@businesstoday.news to get started!
